JANETTE FLEISSNER: Open Payments
NPI 1710665013 · ASHTABULA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$321 in 17 payments from 11 companies in 2025. Trend: 2023 $97 · 2024 $548 · 2025 $321
Food & beverage: $321
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $66 |
| Corcept Therapeutics | 2 | $44 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
| Exact Sciences Corporation | 2 | $28 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $24 |
| ABBVIE INC. | 1 | $24 |
| Novo Nordisk Inc | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
Products named: BREZTRI, Korlym, XIFAXAN, Cologuard Collection Kit, JOURNAVX, UBRELVY, Ozempic, GVOKE HYPOPEN.
Industry payments across OH — which companies pay providers there.
